SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266281.
  • 2
    Forman JP, Giovannucci E, Holmes MD et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:10631069.
  • 3
    Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007;20:713719.
  • 4
    Scragg R, Holdaway I, Singh V et al. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 1995;27:181188.
  • 5
    Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27:28132818.
  • 6
    Pittas AG, Dawson-Hughes B, Li T et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006;29:650656.
  • 7
    Chonchol M, Scragg R. 25-hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 2007;71:134139.
  • 8
    Scragg R, Jackson R, Holdaway IM et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: A community-based study. Int J Epidemiol 1990;19:559563.
  • 9
    Kendrick J, Targher G, Smits G et al. 25-hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2008 Nov 11. [Epub ahead of print].
  • 10
    Giovannucci E, Liu Y, Hollis BW et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med 2008;168:11741180.
  • 11
    Dobnig H, Pilz S, Scharnagl H et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:13401349.
  • 12
    Wang TJ, Pencina MJ, Booth SL et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503511.
  • 13
    Garland C, Comstock GW, Garland FC et al. Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study. Lancet 1989;2:11761178.
  • 14
    Giovannucci E, Liu Y, Rimm EB et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:451459.
  • 15
    Garland CF, Garland FC, Gorham ED et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252261.
  • 16
    Lin J, Manson JE, Lee IM et al. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 2007;167:10501059.
  • 17
    Lappe JM, Travers-Gustafson D et al. Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 2007;85:15861591.
  • 18
    Cannell JJ, Vieth R, Umhau JC et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006;134:11291140.
  • 19
    Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:17701773.
  • 20
    Laaksi I, Ruohola JP, Tuohimaa P et al. An association of serum vitamin D concentrations <40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 2007;86:714717.
  • 21
    Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infections in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384390.
  • 22
    Avenell A, Cook JA, Maclennan GS et al. Vitamin D supplementation to prevent infections: A sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2007;36:574577.
  • 23
    Martineau AR, Wilkinson RJ, Wilkinson KA et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007;176:208213.
  • 24
    Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007;72:10041013.
  • 25
    Melamed ML, Michos ED, Post W. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:16291637.
  • 26
    Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:17301737.
  • 27
    Wolf M, Betacourt J, Chang Y et al. Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 2008;19:13791388.
  • 28
    Kovesdy CP, Ahmadzadeh S, Anderson JE et al. Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 2008;168:397403.
  • 29
    Naves-Diaz M, Alvarez-Hernandez D, Passlick-Deetjen J et al. Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney Int 2008;74:10701078.
  • 30
    Heron MP, Hoyert DL, Xu J et al. Deaths: Preliminary data for 2006. Natl Vital Stat Rep 2007, 152.
  • 31
    Scragg R, Camargo CA Jr. Frequency of leisure time physical activity and serum 25-hydroxyvitamin D levels in the U.S. population: Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2008;168:577586.
  • 32
    Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med 2009;169:626632.
  • 33
    Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, 1999.
  • 34
    Vieth R, Bischoff-Ferrari H, Boucher BJ et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007;85:649650.
  • 35
    Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services. [on-line]. Available at http://www.cdc.gov/nchs/about/major/nhanes/nh3data.htm Accessed January 18, 2009.
  • 36
    Looker AC, Dawson-Hughes B, Calvo MS et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002;30:771777.
  • 37
    Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population. Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:112.
  • 38
    Bischoff-Ferrari HA, Giovannucci E, Willett WC et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:1828.
  • 39
    Scragg R. Sunlight, vitamin D and cardiovascular disease. In: CrassMF, AvioloiLV, editors. Calcium-Regulating Hormones and Cardiovascular Function. Boca Raton: CRC Press, 1995, pp 213237.
  • 40
    Weishaar RE, Kim SN, Saunders DE et al. Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am J Physiol 1990;258:E134E142.
  • 41
    Sugden JA, Davies JI, Witham MD et al. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008;25:320325.
  • 42
    Willheim M, Thien R, Schrattbauer K et al. Regulatory effects of 1alpha,25-dihydroxvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab 1999;84:37393744.
  • 43
    Li YC, Kong J, Wei M et al. 1,25-dihydroxyvitamin D(3) is a negative endocrine regulator of the rennin angiotensin system. J Clin Invest 2002;110:229238.
  • 44
    Timms PM, Mannan N, Hitman GA et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: Mechanisms for inflammatory damage in chronic disorders? OJM 2002;95:787796.
  • 45
    Martins D, Wolf M, Pan D et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007;167:11591165.
  • 46
    Ford ES, Ajani UA, McGuire LC et al. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care 2005;28:12281230.
  • 47
    Barger-Lux MS, Heaney RP, Dowell S et al. Vitamin D and its major metabolites: Serum levels after graded oral dosing in healthy men. Osteoporos Int 1998;8:222230.
  • 48
    Hsia J, Heiss G, Ren H et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007;115:846854.
  • 49
    Michos ED, Blumenthal RS. Vitamin D supplementation and cardiovascular risk [letter]. Circulation 2007;115:827828.
  • 50
    Bacon CJ, Gamble GD, Horne AM et al. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 2009; in press.